The TCGA data indicated that the expression of TMED2 in ovarian cancer was positively correlated with IGF1R (Figure 4C, R=0.28; P=3.2E-09)(http://gepia.cancer-pku.cn/detail.php)[9]. This evidence concerns the gene IGF1R and ovarian cancer.